# Phase 2 Cardiovascular Diseases trials recruiting: 28 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 28 trials in phase 2 for Cardiovascular Diseases that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Cardiovascular Diseases trials: 28 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/cardiovascular-diseases

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 28
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 24, 2026 | NCT07839936 | A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease | Eli Lilly and Company | Phase 2 | Recruiting | Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839936) |
| September 24, 2026 | NCT07837934 | Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes | Tan Tock Seng Hospital | Phase 2 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Atherosclerosis, Cardiovascular Diseases | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837934) |
| August 25, 2026 | NCT07783802 | A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event | Eli Lilly and Company | Phase 2 | Recruiting | Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783802) |
| July 17, 2026 | NCT07712380 | A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults \>=50 Years of Age at Risk for... | GlaxoSmithKline | Phase 2 | Not yet recruiting | Cardiovascular Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07712380) |
| July 15, 2026 | NCT07704164 | Colchicine to Reduce Coronary Artery Inflammation in People With HIV | Instituto de Investigación Hospital Universitario La Paz | Phase 2 | Recruiting | HIV Infection, Cardiovascular Diseases (CVD) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704164) |
| July 6, 2026 | NCT07685938 | Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease | UNC Lineberger Comprehensive Cancer Center | Phase 2 | Recruiting | Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07685938) |
| May 13, 2026 | NCT07584967 | A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure | AnaCardio AB | Phase 2 | Recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07584967) |
| March 10, 2026 | NCT07460960 | TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men | Lomonosov Moscow State University Medical Research and Educational Center | Phase 2 | Recruiting | Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07460960) |
| January 12, 2026 | NCT07333183 | A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD | Pulmovant, Inc. | Phase 2 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease (ILD), Lung Diseases, Vascular Diseases, Cardiovascular Diseases... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07333183) |
| December 26, 2025 | NCT07304817 | Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) | University Medical Center Groningen | Phase 2 | Recruiting | CKD, Cardiovascular Diseases, Heart Failure | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07304817) |
| October 27, 2025 | NCT07221214 | GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV | Vanderbilt University Medical Center | Phase 2 | Recruiting | HIV, Alcohol, Smoking Cigarette, Cardiovascular Disease Prevention | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07221214) |
| August 21, 2025 | NCT07134712 | Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II | HONYA Medical Co Ltd | Phase 2 | Not yet recruiting | Acute Myocardial Infarction (AMI) | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07134712) |
| July 22, 2025 | NCT07078344 | Omega-3D: Omega-3 for Diet-Driven Health Disparities | University of Arizona | Phase 2 | Recruiting | Heart Health Markers, Cardiovascular Diseases, Omega 3 Fatty Acids | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07078344) |
| April 16, 2025 | NCT06929169 | Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study | Sponsor not shown (see the record) | Phase 2 | Recruiting | Chronic Kidney Disease Requiring Hemodialysis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06929169) |
| February 14, 2025 | NCT06826872 | Efficacy and Safety of SPC1001 in Patients With Essential Hypertension | Shin Poong Pharmaceutical Co. Ltd. | Phase 2 | Recruiting | Hypertension, Essential, Cardiovascular Diseases, Cardiology | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06826872) |
| November 12, 2024 | NCT06683534 | Palmitic Acid and Human Microvascular Function | Medical College of Wisconsin | Phase 2 | Not yet recruiting | Microvascular Dysfunction, Microvasculature, Cardiovascular Diseases, Cardiovascular Diseases (CVD), Microvascular... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06683534) |
| October 28, 2024 | NCT06661538 | Implementing Food Referrals for Equity and Sustained Health | University of California, San Diego | Phase 2 | Recruiting | Food Insecurity | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06661538) |
| October 17, 2024 | NCT06645691 | Hyperpolarized MR Imaging With Carbon-13 Pyruvate in the Human Body | National Heart Centre Singapore | Phase 2 | Recruiting | Heart Failure, Cardiometabolic Syndrome, Cancer Diagnosis, Cardiovascular Diseases, Healthy Volunteers | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06645691) |
| July 5, 2024 | NCT06488105 | Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial | Wake Forest University Health Sciences | Phase 2 | Recruiting | Lipid Disorder, Hypercholesterolemia, Cardiovascular Diseases, Atherosclerosis | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06488105) |
| May 22, 2024 | NCT06424756 | Effects of an Antioxidant Supplement on Blood Vessel Health | University of Georgia | Phase 2 | Recruiting | Healthy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06424756) |
| March 20, 2024 | NCT06320951 | VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate... | University of Alabama at Birmingham | Phase 2 | Not yet recruiting | Cardiovascular Diseases, Insulin Sensitivity/Resistance, Metabolic Disease, Metabolism, Energy Expenditure, Obesity | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06320951) |
| August 4, 2022 | NCT05488431 | Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) | Sponsor not shown (see the record) | Phase 2 | Recruiting | Dyslipidemias, Cardiovascular Diseases, HIV Infections, Atherosclerosis | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05488431) |
| July 25, 2022 | NCT05472337 | Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome | Pontificia Universidad Catolica de Chile | Phase 2 | Recruiting | Acute Coronary Syndrome | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05472337) |
| June 30, 2022 | NCT05440422 | The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 2 | Recruiting | Systemic Lupus Erythematosus, Cardiovascular Disease, Premature Atherosclerosis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05440422) |
| March 21, 2022 | NCT05288790 | Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT | Vanderbilt University Medical Center | Phase 2 | Recruiting | Microtia, Dysbiosis, Alcohol Drinking, HIV Infections, Cardiovascular Diseases | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05288790) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Alabama at Birmingham | 2 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 2 |
| Vanderbilt University Medical Center | 2 |
| Pulmovant, Inc. | 1 |
| Pontificia Universidad Catolica de Chile | 1 |
| Instituto de Investigación Hospital Universitario La Paz | 1 |
| Nationwide Children's Hospital | 1 |
| National Heart Centre Singapore | 1 |
| [Shin Poong Pharmaceutical Co. Ltd.](https://specstream.ai/data/clinical-trials/company/shin-poong-pharmaceutical-co-ltd) | 1 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| University of California, San Diego | 1 |
| Medical College of Wisconsin | 1 |
| HONYA Medical Co Ltd | 1 |
| University Medical Center Groningen | 1 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
| University of Georgia | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
| Lomonosov Moscow State University Medical Research and Educational Center | 1 |
| Tan Tock Seng Hospital | 1 |
| AnaCardio AB | 1 |
| University of Arizona | 1 |
| Wake Forest University Health Sciences | 1 |
| Turku University Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 17 |
| Spain | 2 |
| Singapore | 2 |
| Argentina | 2 |
| Sweden | 2 |
| Chile | 1 |
| South Korea | 1 |
| Australia | 1 |
| Taiwan | 1 |
| Netherlands | 1 |
| Japan | 1 |
| Puerto Rico | 1 |
| Russia | 1 |
| Bulgaria | 1 |
| Canada | 1 |
| Czechia | 1 |
| Poland | 1 |
| Slovakia | 1 |
| Finland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fireplace services in the United States](https://specstream.ai/data/businesses/fireplace-services/united-states)
- [Generator installation repair companies in the United States](https://specstream.ai/data/businesses/generator-installation-repair-companies/united-states)
- [High schools in the United States](https://specstream.ai/data/businesses/high-schools/united-states)
- [Hyperbaric medicine centers in the United States](https://specstream.ai/data/businesses/hyperbaric-medicine-centers/united-states)
- [Iron fabricators in the United States](https://specstream.ai/data/businesses/iron-fabricators/united-states)
- [Lawn care companies in the United States](https://specstream.ai/data/businesses/lawn-care-companies/united-states)
